SCWCX
Price
$68.41
Change
+$0.57 (+0.84%)
Updated
Jun 22 closing price
Net Assets
91.47B
TGSAX
Price
$10.57
Change
-$0.07 (-0.66%)
Updated
Jun 22 closing price
Net Assets
816.62M
Interact to see
Advertisement

SCWCX vs TGSAX

SCWCX vs TGSAX Comparison Chart in %
View a ticker or compare two or three
VS
SCWCX vs. TGSAX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCWCX is a Buy and TGSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SCWCX has more cash in the bank: 91.5B vs. TGSAX (817M). TGSAX pays higher dividends than SCWCX: TGSAX (1.42) vs SCWCX (0.15). SCWCX was incepted earlier than TGSAX: SCWCX (25 years) vs TGSAX (29 years). SCWCX (1.77) is less costly to investors than TGSAX (1.09). SCWCX is a more actively managed with annual turnover of: 41.00 vs. TGSAX (15.75). SCWCX has a lower initial minimum investment than TGSAX: SCWCX (250) vs TGSAX (100000). SCWCX annual gain was more profitable for investors over the last year : 21.72 vs. TGSAX (16.30). SCWCX return over 5 years is better than : -7.31 vs. TGSAX (-8.98).
SCWCXTGSAXSCWCX / TGSAX
Total Expense Ratio1.771.09162%
Annual Report Gross Expense Ratio1.771.09162%
Fund Existence25 years29 years-
Gain YTD16.42311.181147%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets91.5B817M11,200%
Annual Yield % from dividends0.151.4211%
Returns for 1 year21.7216.30133%
Returns for 3 years38.2927.81138%
Returns for 5 years-7.31-8.9881%
Returns for 10 years80.6041.07196%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACFOX82.27N/A
N/A
American Century Focused Dynamic Gr Inv
UMBHX28.65N/A
N/A
Carillon Chartwell Small Cap I
AMTAX11.54N/A
N/A
AB All Market Real Return A
MDOBX12.01N/A
N/A
Morgan Stanley Developing Opportunity C
JVACX39.17N/A
N/A
JPMorgan Value Advantage C